CARA THERAPEUTICS INC. - COMMON STOCK
0.3051
22-11月-24 16:44:58
15 分の遅延
株式
-0.0049
-1.58%
本日の幅
0.2831 - 0.3160
ISIN
N/A
ソース
NASDAQ
-
28 9 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
12 9 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
08 9 2022 08:15:00 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06 9 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Host Virtual Notalgia Paresthetica Event on September 20, 2022
24 8 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
22 8 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
19 8 2022 01:00:00 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics Reports Second Quarter 2022 Financial Results
08 8 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference
03 8 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Announce Second Quarter 2022 Financial Results on August 8, 2022
01 8 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
30 6 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at Upcoming Investor Conferences
17 5 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics Reports First Quarter 2022 Financial Results
09 5 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at May Investor Conferences
03 5 2022 16:01:00 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022
29 4 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
28 4 2022 01:00:00 提供 Nasdaq GlobeNewswire
-
Cara Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
05 4 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
28 3 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
08 3 2022 16:01:00 提供 Nasdaq GlobeNewswire